Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity

The adenosine A₁ receptor (A₁-AR) is a G-protein-coupled receptor that plays a vital role in cardiac, renal, and neuronal processes but remains poorly targeted by current drugs. We determined a 3.2 Å crystal structure of the A₁-AR bound to the selective covalent antagonist, DU172, and identified striking differences to the previously solved adenosine A_2A receptor (A_2A-AR) structure. Mutational and computational analysis of A₁-AR revealed a distinct conformation of the second extracellular loop and a wider extracellular cavity with a secondary binding pocket that can accommodate orthosteric and allosteric ligands. We propose that conformational differences in these regions, rather than amino-acid divergence, underlie drug selectivity between these Adenosine Receptor subtypes. Our findings provide a molecular basis for AR subtype selectivity with implications for understanding the mechanisms governing allosteric modulation of these receptors, allowing the design of more selective agents for the treatment of ischemia-reperfusion injury, renal pathologies, and neuropathic pain.

G-protein-coupled receptor; adenosine; allosteric modulation; cardiovascular disease; crystallography; drug design; drug discovery; ischemia-reperfusion; neuropathic pain; structural biology.